Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad A Rafi

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Genetics and Metabolism|June 18, 2003
Mutation analysis of feline Niemann-Pick C1 diseaseKyra L Somers, Michael A Royals, Eugene D Carstea, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2005
AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2Darshong Lin, Corinne R Fantz, Beth Levy, et al.
Molecular Genetics and Metabolism|September 20, 2005
Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantationPaola Luzi, Mohammad A Rafi, Mariam Zaka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophyMohammad A Rafi, Han Zhi Rao, Marco A Passini, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Genetics and Metabolism|June 18, 2003
Mutation analysis of feline Niemann-Pick C1 diseaseKyra L Somers, Michael A Royals, Eugene D Carstea, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2005
AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2Darshong Lin, Corinne R Fantz, Beth Levy, et al.
Molecular Genetics and Metabolism|September 20, 2005
Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantationPaola Luzi, Mohammad A Rafi, Mariam Zaka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophyMohammad A Rafi, Han Zhi Rao, Marco A Passini, et al.
Pageof 4